vs
Porch Group, Inc.（PRCH）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Porch Group, Inc.的1.0倍（$127.1M vs $121.1M），Porch Group, Inc.同比增速更快（100.0% vs 17.1%），过去两年Porch Group, Inc.的营收复合增速更高（26.4% vs 20.8%）
Porch Group是一家面向屋主的家居改造服务平台，致力于连接屋主与当地的家居装修承包商。平台不仅提供超过160种家居装修项目的在线预约服务，还涵盖专业建议文章与装修成本指南，帮助屋主便捷规划各类家装工程。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PRCH vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.0倍
$121.1M
营收增速更快
PRCH
高出82.9%
17.1%
两年增速更快
PRCH
近两年复合增速
20.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.1M | $127.1M |
| 净利润 | $-4.7M | — |
| 毛利率 | 52.7% | 51.0% |
| 营业利润率 | 34.7% | -54.6% |
| 净利率 | -3.9% | — |
| 营收同比 | 100.0% | 17.1% |
| 净利润同比 | 2.0% | — |
| 每股收益（稀释后） | $-0.04 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRCHZLAB
| Q1 26 | $121.1M | — | ||
| Q4 25 | $112.3M | $127.1M | ||
| Q3 25 | $115.1M | $115.4M | ||
| Q2 25 | $107.0M | $109.1M | ||
| Q1 25 | $84.5M | $105.7M | ||
| Q4 24 | $75.3M | $108.5M | ||
| Q3 24 | $77.7M | $101.8M | ||
| Q2 24 | $75.9M | $100.1M |
净利润PRCHZLAB
| Q1 26 | $-4.7M | — | ||
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-10.9M | $-36.0M | ||
| Q2 25 | $2.6M | $-40.7M | ||
| Q1 25 | $8.4M | $-48.4M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $14.4M | $-41.7M | ||
| Q2 24 | $-64.3M | $-80.3M |
毛利率PRCHZLAB
| Q1 26 | 52.7% | — | ||
| Q4 25 | 99.5% | 51.0% | ||
| Q3 25 | 75.6% | 59.5% | ||
| Q2 25 | 70.9% | 60.6% | ||
| Q1 25 | 77.4% | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | 79.4% | 64.1% | ||
| Q2 24 | 22.1% | 64.9% |
营业利润率PRCHZLAB
| Q1 26 | 34.7% | — | ||
| Q4 25 | 14.7% | -54.6% | ||
| Q3 25 | 14.2% | -42.3% | ||
| Q2 25 | 4.7% | -50.3% | ||
| Q1 25 | -1.5% | -53.3% | ||
| Q4 24 | 33.3% | -62.6% | ||
| Q3 24 | -3.2% | -66.6% | ||
| Q2 24 | -69.2% | -76.0% |
净利率PRCHZLAB
| Q1 26 | -3.9% | — | ||
| Q4 25 | -3.1% | — | ||
| Q3 25 | -9.4% | -31.2% | ||
| Q2 25 | 2.4% | -37.3% | ||
| Q1 25 | 9.9% | -45.8% | ||
| Q4 24 | 40.5% | — | ||
| Q3 24 | 18.5% | -40.9% | ||
| Q2 24 | -84.8% | -80.2% |
每股收益（稀释后）PRCHZLAB
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $0.00 | $-0.05 | ||
| Q3 25 | $-0.10 | $-0.03 | ||
| Q2 25 | $0.00 | $-0.04 | ||
| Q1 25 | $0.07 | $-0.04 | ||
| Q4 24 | $0.34 | $-0.09 | ||
| Q3 24 | $0.12 | $-0.04 | ||
| Q2 24 | $-0.65 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $68.4M | $689.6M |
| 总债务越低越好 | $391.3M | — |
| 股东权益账面价值 | $26.3M | $715.5M |
| 总资产 | $806.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 14.87× | — |
8季度趋势，按日历期对齐
现金及短期投资PRCHZLAB
| Q1 26 | $68.4M | — | ||
| Q4 25 | $57.3M | $689.6M | ||
| Q3 25 | $85.0M | $717.2M | ||
| Q2 25 | $79.8M | $732.2M | ||
| Q1 25 | $70.4M | $757.3M | ||
| Q4 24 | $191.7M | $779.7M | ||
| Q3 24 | $238.6M | $616.1M | ||
| Q2 24 | $308.4M | $630.0M |
总债务PRCHZLAB
| Q1 26 | $391.3M | — | ||
| Q4 25 | $392.8M | — | ||
| Q3 25 | $387.1M | — | ||
| Q2 25 | $394.1M | — | ||
| Q1 25 | $409.2M | — | ||
| Q4 24 | $403.9M | — | ||
| Q3 24 | $399.0M | — | ||
| Q2 24 | $436.8M | — |
股东权益PRCHZLAB
| Q1 26 | $26.3M | — | ||
| Q4 25 | $-24.6M | $715.5M | ||
| Q3 25 | $-27.9M | $759.9M | ||
| Q2 25 | $-29.3M | $791.7M | ||
| Q1 25 | $-52.4M | $810.8M | ||
| Q4 24 | $-43.2M | $840.9M | ||
| Q3 24 | $-77.0M | $667.7M | ||
| Q2 24 | $-101.9M | $704.2M |
总资产PRCHZLAB
| Q1 26 | $806.6M | — | ||
| Q4 25 | $797.4M | $1.2B | ||
| Q3 25 | $787.7M | $1.2B | ||
| Q2 25 | $770.7M | $1.2B | ||
| Q1 25 | $802.3M | $1.2B | ||
| Q4 24 | $814.0M | $1.2B | ||
| Q3 24 | $867.3M | $985.3M | ||
| Q2 24 | $876.1M | $987.4M |
负债/权益比PRCHZLAB
| Q1 26 | 14.87× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PRCHZLAB
| Q1 26 | — | — | ||
| Q4 25 | $1.2M | $-26.0M | ||
| Q3 25 | $40.8M | $-32.0M | ||
| Q2 25 | $35.6M | $-31.0M | ||
| Q1 25 | $-11.2M | $-61.7M | ||
| Q4 24 | $-26.6M | $-55.8M | ||
| Q3 24 | $12.4M | $-26.8M | ||
| Q2 24 | $-26.0M | $-42.2M |
自由现金流PRCHZLAB
| Q1 26 | — | — | ||
| Q4 25 | $1.1M | $-26.7M | ||
| Q3 25 | $40.7M | $-35.0M | ||
| Q2 25 | $35.4M | $-33.9M | ||
| Q1 25 | $-11.2M | $-63.2M | ||
| Q4 24 | $-26.8M | $-58.4M | ||
| Q3 24 | $12.2M | $-28.2M | ||
| Q2 24 | $-26.0M | $-42.9M |
自由现金流率PRCHZLAB
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | -21.0% | ||
| Q3 25 | 35.4% | -30.4% | ||
| Q2 25 | 33.0% | -31.1% | ||
| Q1 25 | -13.3% | -59.9% | ||
| Q4 24 | -35.6% | -53.8% | ||
| Q3 24 | 15.7% | -27.7% | ||
| Q2 24 | -34.3% | -42.9% |
资本支出强度PRCHZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | 0.3% | 1.3% | ||
| Q2 24 | 0.1% | 0.7% |
现金转化率PRCHZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 13.79× | — | ||
| Q1 25 | -1.33× | — | ||
| Q4 24 | -0.87× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRCH
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
